Expedition Therapeutics, Inc
1 clinical trials · Sponsor
◉ Watch Expedition Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment (NCT07684820) | Expedition Therapeutics, Inc | 2026-06-30 |
Track Expedition Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.